Gaard Labs launches with focus on New York market
A new CBD brand is hitting the market with the aim of being a major player among consumers in New York state. Gaard Labs is making its debut at several independent sellers in New York City and throughout the state.
Gaard Labs’ initial collection includes Relief Balm, Relief Roll-On with Lidocaine, Calm Oral Spray, Focus Oral Spray, Relief Say Oral Spray and Relief Night Oral Spray. The needs-focused products physician-formulated ratios of broad-spectrum cannabinoids, terpenes and active pharmaceutical ingredients.
"As a Manhattan native, it's a privilege to launch our brand from New York City," said Steven Levy, co-founder.
CEO David Meister said the company sees big opportunity in the Empire State. "New York is developing the nation's most stringent regulatory hemp and marijuana cannabis frameworks, while remaining focused on the highest standards of consumer safety. It's a perfect fit for us."
Early partnerships include Manhattan-based retailer Willner Chemists, the continent’s largest and oldest nutritionally focused pharmacy, as well as Empire Nutrition, which has various supplement/vitamin stores throughout the state. Not sticking just to the East Coast, Gaard Labs also has launched in partnership with Pacifica Compounding Pharmacy in Torrance, Calif.
The company said that it works with a Manhattan-based fulfillment center in New York, and a fulfillment center in Cicero, Ill., for all of its nationwide e-commerce and retail distribution.
